The identified upregulation of ABCB5 in plaques from patients scored as high-risk by both ABCD2 and CAR, emphasizes the significance of IPH in plaque instability, suggesting that the role of ABCB5 in atherosclerosis should be mechanistically explored and its potential as a therapeutic target investigated. Here, ABCB5 is linked to atherosclerosis.